Bernstein Sees Attractive Entry in UnitedHealth (UNH) Stock Ahead of Q2 Earnings

UnitedHealth Group Incorporated (NYSE:UNH) ranks among the best non-tech stocks to buy according to billionaires. On July 18, Bernstein referred to UnitedHealth Group Incorporated (NYSE:UNH) as a Top Pick ahead of the company’s upcoming Q2 earnings, stating that the stock’s decline as a result of the continued challenges has led to a “very attractive entry point.”

According to analyst Lance Wilkes, UNH will profit from a “hardening” of the government Managed Care Organization (MCO) pricing market and a slowdown in utilization to normal levels. In light of reserve strengthening, cost challenges in the Individual and Medicaid businesses, and the “clean-up of OptumHealth risk contracts for less engaged physician practices,” Wilkes reduced his 2025 EPS projection by 10%.

Wilkes also predicts that, after accounting for slower growth rates in UnitedHealthcare Medicare Advantage and OptumHealth, the sector and company-specific margins will produce a doubling of EPS from 2025 to 2029 at a CAGR of 19%.

UnitedHealth Group Incorporated (NYSE:UNH) is a renowned US multinational corporation that provides managed healthcare and insurance services. The company operates through four main segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx.

While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

Read More: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds

Disclosure: None.